Management of Kawasaki disease in the British Isles

Archives of Disease in Childhood

Volumn 69, Issue 6, 1993, Pages 631-638

  Dhillon, R ^a   Newton, L ^a   Rudd, P T ^a   Hall, S M ^a   Levin, M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; DIPYRIDAMOLE; IMMUNOGLOBULIN; PREDNISOLONE;

AGE; ARTICLE; CHILD; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOCYTOSIS; UNITED KINGDOM;

EID: 0027134580     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.69.6.631     Document Type: Article

References (4)

1. NewburgerJW, Burns J.C. Kawasaki syndrome Cardiol Clin 1989 10.1016/S0733-8651(18)30448-X 7 453
2. Furusho, K.; Kamiya, T.; Nakano, H. High dose intravenous gammaglobulin for Kawasaki disease Lancet 1984 10.1016/S0140-6736(84)91504-6 ii: 1055
3. Nagashima, M.; Matsushima, M.; Matsuoka, H.; Ogawa, A.; KOakwuamsawkai, N. High dose disease. Pediatr gammaglobulin therapy 1987 110 710
4. Greenbaum, B.H. Differences in immunoglobulin preparations for intravenous use: a comparison of six products AmJ Pediatr Hematol Oncol 1990 10.1097/00043426-199024000-00015 12 490